BioMarin Pharmaceutical Inc. buy Wedbush
Start price
28.10.25
/
50%
€46.07
Target price
28.10.26
€80.63
Performance (%)
12.96%
Price
25.02.26
€52.04
Summary
This prediction is currently active. The prediction currently has a performance of 12.96%. This prediction currently runs until 28.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.838% | -0.838% |
| iShares Core DAX® | 0.048% | 1.311% |
| iShares Nasdaq 100 | 1.601% | -0.902% |
| iShares Nikkei 225® | 3.057% | 12.947% |
| iShares S&P 500 | 0.820% | 0.703% |
Comments by Wedbush for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wedbush for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€53.52
05.08.25
05.08.25
€81.32
05.08.26
05.08.26
-2.77%
25.02.26
25.02.26

